Half of people with Prader-Willi syndrome (PWS) treated with the antipsychotic aripiprazole in a small German study experienced fewer…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Cells of adipose tissue, or body fat, may go awry long before weight gain takes off in children with…
There may be changes to how the “feel-good” hormone oxytocin works in patients with Prader-Willi syndrome (PWS) in general, and…
People with Prader-Willi syndrome (PWS) who had COVID-19 experienced either no symptoms or only mild illness due to the…
Two boys with Prader-Willi syndrome (PWS) developed respiratory failure — a condition in which the oxygen level in the…
Subtle heart changes in people with Prader–Willi syndrome (PWS) may begin relatively early in adulthood, and being overweight may…
Prader–Willi syndrome (PWS) is associated with a specific molecular signature — a set of genes that can be used…
Specific epigenetic modifications — chemical marks added to DNA that affect the way genes work — are found in people…
Twice daily supplementation with a probiotic may help reduce body mass index (BMI), a measure of body fat, in patients…
A protein that interacts with insulin growth factor 1 (IGF1) may be important in managing children with Prader–Willi syndrome…